Full Text View
Tabular View
No Study Results Posted
Related Studies
Study Evaluating Two Dose Levels of Targretin Capsules in Patients With Refractory Cutaneous T-cell Lymphoma (CTCL)
This study has been completed.
Study NCT01007448   Information provided by Valeant Pharmaceuticals International, Inc.

First Received on November 3, 2009.   Last Updated on June 1, 2015   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
More general drug interventions related to this trial
Sponsors listed in this trial